Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BenevolentAI
Biotech
Less than a year in, BenevolentAI CEO is out—Chutes & Ladders
Less than a year in, BenevolentAI CEO is out. Deshaies descends from Amgen research perch. Sage’s reorg scrambles executive team.
Darren Incorvaia
,
Zoey Becker
Oct 18, 2024 8:30am
Big pharma, biotech ‘won't necessarily be symbiotic’ in AI: S&P
Oct 2, 2024 11:23am
BenevolentAI lays off 30% of staff, exits US site in latest cuts
Apr 23, 2024 7:35am
Bayer undergoes leadership shake-up—Chutes & Ladders
Mar 22, 2024 9:30am
Pfizer's migraine market chief joins Apnimed—Chutes & Ladders
Jan 26, 2024 9:30am
BenevolentAI names ex-Bayer R&D chief as new CEO
Jan 24, 2024 10:20am
